(S)-nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of ASCL1 mRNA CTD PMID:28555334 1,8-cineole decreases expression ISO RGD:736393 6480464 Eucalyptol results in decreased expression of ASCL1 mRNA CTD PMID:36331666 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of ASCL1 mRNA CTD PMID:30723492 17beta-estradiol multiple interactions ISO RGD:736393 6480464 [Estradiol binds to ESR2 protein] which results in increased expression of ASCL1 mRNA, [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ASCL1 mRNA CTD PMID:19619570 , PMID:20404318 17beta-estradiol decreases expression ISO RGD:736393 6480464 Estradiol results in decreased expression of ASCL1 mRNA CTD PMID:31614463 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of ASCL1 mRNA CTD PMID:20068009 17beta-estradiol increases expression ISO RGD:736393 6480464 Estradiol results in increased expression of ASCL1 mRNA CTD PMID:19619570 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732027 6480464 Tetrachlorodibenzodioxin affects the expression of ASCL1 mRNA CTD PMID:21570461 , PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ASCL1 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:736393 6480464 Tetrachlorodibenzodioxin results in decreased expression of ASCL1 mRNA CTD PMID:19619570 , PMID:19901195 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:736393 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of ASCL1 mRNA CTD PMID:19619570 2,3,7,8-Tetrachlorodibenzofuran increases expression EXP 6480464 2 more ... CTD PMID:32109520 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of ASCL1 mRNA CTD PMID:21346803 2-methylcholine affects expression ISO RGD:736393 6480464 beta-methylcholine affects the expression of ASCL1 mRNA CTD PMID:21179406 3-methylcholanthrene multiple interactions ISO RGD:732027 6480464 [Methylcholanthrene co-treated with Nanotubes, Carbon] results in increased expression of ASCL1 mRNA CTD PMID:25926378 4,4'-diaminodiphenylmethane increases expression ISO RGD:732027 6480464 4, 4'-diaminodiphenylmethane results in increased expression of ASCL1 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol decreases expression ISO RGD:732027 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of ASCL1 mRNA CTD PMID:30951980 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of ASCL1 mRNA CTD PMID:24780913 Actein decreases expression EXP 6480464 actein results in decreased expression of ASCL1 protein CTD PMID:29969672 afimoxifene decreases expression ISO RGD:736393 6480464 afimoxifene results in decreased expression of ASCL1 mRNA CTD PMID:19901195 afimoxifene increases expression ISO RGD:736393 6480464 afimoxifene results in increased expression of ASCL1 mRNA CTD PMID:16849584 all-trans-retinoic acid increases expression ISO RGD:736393 6480464 Tretinoin results in increased expression of ASCL1 mRNA CTD PMID:21934132 all-trans-retinoic acid increases expression ISO RGD:732027 6480464 Tretinoin results in increased expression of ASCL1 mRNA CTD PMID:34627992 all-trans-retinoic acid decreases expression ISO RGD:736393 6480464 Tretinoin results in decreased expression of ASCL1 mRNA CTD PMID:23724009 all-trans-retinol increases expression EXP 6480464 Vitamin A deficiency results in increased expression of ASCL1 mRNA CTD PMID:12555267 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ASCL1 mRNA CTD PMID:16483693 arotinoid acid multiple interactions ISO RGD:736393 6480464 [4-(2-(5 more ... CTD PMID:34480604 arsane decreases expression ISO RGD:732027 6480464 Arsenic results in decreased expression of ASCL1 mRNA CTD PMID:24019935 , PMID:33124703 arsenic atom decreases expression ISO RGD:732027 6480464 Arsenic results in decreased expression of ASCL1 mRNA CTD PMID:24019935 , PMID:33124703 atrazine decreases expression ISO RGD:736393 6480464 Atrazine results in decreased expression of ASCL1 mRNA CTD PMID:22378314 benzo[a]pyrene affects methylation ISO RGD:736393 6480464 Benzo(a)pyrene affects the methylation of ASCL1 3' UTR, Benzo(a)pyrene affects the methylation of ASCL1 exon CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:736393 6480464 Benzo(a)pyrene results in increased methylation of ASCL1 5' UTR, Benzo(a)pyrene results in increased methylation of ASCL1 promoter CTD PMID:27901495 bexarotene multiple interactions EXP 6480464 [bexarotene co-treated with Tamoxifen] results in decreased expression of ASCL1 mRNA CTD PMID:17630414 bisphenol A increases expression ISO RGD:732027 6480464 bisphenol A results in increased expression of ASCL1 mRNA CTD PMID:26063408 , PMID:30951980 bisphenol A affects methylation ISO RGD:732027 6480464 bisphenol A affects the methylation of ASCL1 promoter CTD PMID:27334623 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ASCL1 mRNA CTD PMID:25181051 , PMID:35192832 bisphenol F decreases expression ISO RGD:732027 6480464 bisphenol F results in decreased expression of ASCL1 mRNA CTD PMID:30951980 bosentan affects expression ISO RGD:736393 6480464 Bosentan affects the expression of ASCL1 mRNA CTD PMID:29761207 carbon nanotube multiple interactions ISO RGD:732027 6480464 [Methylcholanthrene co-treated with Nanotubes, Carbon] results in increased expression of ASCL1 mRNA CTD PMID:25926378 carbon nanotube decreases expression ISO RGD:732027 6480464 Nanotubes more ... CTD PMID:25554681 CHIR 99021 multiple interactions ISO RGD:736393 6480464 [4-(2-(5 more ... CTD PMID:34480604 cortisol multiple interactions ISO RGD:736393 6480464 [4-(2-(5 more ... CTD PMID:34480604 Cyclopamine decreases expression EXP 6480464 cyclopamine results in decreased expression of ASCL1 mRNA CTD PMID:21703336 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of ASCL1 mRNA CTD PMID:23914054 deguelin increases expression ISO RGD:736393 6480464 deguelin results in increased expression of ASCL1 mRNA CTD PMID:33512557 disodium selenite decreases expression ISO RGD:736393 6480464 Sodium Selenite results in decreased expression of ASCL1 mRNA CTD PMID:18175754 dorsomorphin multiple interactions ISO RGD:736393 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 ellagic acid increases expression ISO RGD:736393 6480464 Ellagic Acid results in increased expression of ASCL1 mRNA CTD PMID:12002526 ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of ASCL1 mRNA CTD PMID:20080153 L-ascorbic acid multiple interactions ISO RGD:736393 6480464 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ASCL1 mRNA CTD PMID:34480604 L-ascorbic acid 2-phosphate multiple interactions ISO RGD:736393 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ASCL1 mRNA CTD PMID:34480604 maneb multiple interactions ISO RGD:732027 6480464 [SNCA protein co-treated with Maneb co-treated with Paraquat] results in decreased expression of ASCL1 mRNA CTD PMID:23017109 methylmercury chloride increases expression ISO RGD:736393 6480464 methylmercuric chloride results in increased expression of ASCL1 mRNA CTD PMID:28001369 naphthalene multiple interactions ISO RGD:736393 6480464 ASCL1 protein inhibits the reaction [naphthalene results in decreased expression of CYP2F2 mRNA] more ... CTD PMID:20554700 naphthalene increases expression ISO RGD:732027 6480464 naphthalene results in increased expression of ASCL1 protein CTD PMID:20554700 nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of ASCL1 mRNA CTD PMID:28555334 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of ASCL1 mRNA CTD PMID:17618886 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of ASCL1 mRNA CTD PMID:21703336 ochratoxin A multiple interactions EXP 6480464 SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of ASCL1 mRNA] CTD PMID:21703336 panobinostat multiple interactions ISO RGD:736393 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASCL1 mRNA CTD PMID:27188386 paraquat multiple interactions ISO RGD:732027 6480464 [SNCA protein co-treated with Maneb co-treated with Paraquat] results in decreased expression of ASCL1 mRNA CTD PMID:23017109 phenylmercury acetate increases expression ISO RGD:736393 6480464 Phenylmercuric Acetate results in increased expression of ASCL1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:736393 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASCL1 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:736393 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ASCL1 mRNA CTD PMID:19710929 poly(ethylene) decreases expression ISO RGD:736393 6480464 Polyethylene results in decreased expression of ASCL1 mRNA CTD PMID:23203475 propionic acid decreases expression ISO RGD:736393 6480464 propionic acid results in decreased expression of ASCL1 mRNA, propionic acid results in decreased expression of ASCL1 protein CTD PMID:31526819 resveratrol decreases expression ISO RGD:736393 6480464 resveratrol results in decreased expression of ASCL1 mRNA, resveratrol results in decreased expression of ASCL1 protein CTD PMID:21184191 resveratrol increases expression ISO RGD:736393 6480464 resveratrol results in increased expression of ASCL1 mRNA CTD PMID:12002526 sarin increases expression ISO RGD:736393 6480464 Sarin results in increased expression of ASCL1 mRNA CTD PMID:19522546 sarin decreases expression ISO RGD:736393 6480464 Sarin results in decreased expression of ASCL1 mRNA CTD PMID:19522546 SB 431542 multiple interactions ISO RGD:736393 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 , PMID:34480604 silver atom decreases expression ISO RGD:736393 6480464 Silver results in decreased expression of ASCL1 mRNA CTD PMID:26551752 silver(0) decreases expression ISO RGD:736393 6480464 Silver results in decreased expression of ASCL1 mRNA CTD PMID:26551752 sodium arsenite decreases expression ISO RGD:732027 6480464 sodium arsenite results in decreased expression of ASCL1 mRNA CTD PMID:25448440 , PMID:27158593 Soman increases expression EXP 6480464 Soman results in increased expression of ASCL1 mRNA CTD PMID:19281266 tamoxifen multiple interactions EXP 6480464 [bexarotene co-treated with Tamoxifen] results in decreased expression of ASCL1 mRNA CTD PMID:17630414 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ASCL1 mRNA CTD PMID:31150632 thapsigargin increases expression ISO RGD:736393 6480464 Thapsigargin results in increased expression of ASCL1 mRNA CTD PMID:22378314 titanium dioxide decreases expression ISO RGD:732027 6480464 titanium dioxide results in decreased expression of ASCL1 mRNA CTD PMID:23557971 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of ASCL1 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:736393 6480464 trichostatin A results in increased expression of ASCL1 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:736393 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASCL1 mRNA CTD PMID:27188386 uranium atom increases expression EXP 6480464 Uranium results in increased expression of ASCL1 mRNA CTD PMID:27639536 valproic acid decreases expression ISO RGD:736393 6480464 Valproic Acid results in decreased expression of ASCL1 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:736393 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASCL1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:736393 6480464 Valproic Acid results in increased expression of ASCL1 mRNA CTD PMID:23179753 , PMID:26272509 venlafaxine hydrochloride increases expression EXP 6480464 Venlafaxine Hydrochloride results in increased expression of ASCL1 mRNA CTD PMID:25423262 venlafaxine hydrochloride decreases expression EXP 6480464 Venlafaxine Hydrochloride results in decreased expression of ASCL1 mRNA CTD PMID:25423262 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of ASCL1 mRNA CTD PMID:23869203 vorinostat increases expression ISO RGD:736393 6480464 vorinostat results in increased expression of ASCL1 mRNA CTD PMID:26272509 vorinostat multiple interactions ISO RGD:736393 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASCL1 mRNA CTD PMID:27188386 XAV939 multiple interactions ISO RGD:736393 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ASCL1 mRNA, [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ASCL1 mRNA CTD PMID:34480604